drug · small molecule
deupirfenidone
Phase 2updated 6mo agoby Celea Therapeutics🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
indications
indications
Pulmonary Fibrosis
all catalysts(0)
nothing on the calendar yet
Trials studying deupirfenidone
News(2)
- A PureTech startup banks $180M for a new IPF drugCelea, backed by investors such as RA Capital and Leaps by Bayer, is making what it says is an improved version of Roche's Esbriet.biopharma_dive · 4mo ago
- Fierce Biotech Fundraising Tracker '26: China's Eli Radiopharma raises $60M; Neurosterix notches $105MThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.fiercebiotech · 10mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that